Appropriate antibiotic utilization in seniors prior to hospitalization for community-acquired pneumonia is associated with decreased in-hospital mortality

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 3, 2004, Pages 231-239

  Johnson, D ^a,d   Carriere, K C ^a   Jin, Y ^b   Marrie, T ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Information Analysis   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d NONE   (Canada)

Author keywords

Antibiotics; Community acquired pneumonia; Health service utilization

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G;

ADULT; AGED; ARTICLE; CANADA; COMMUNITY ACQUIRED PNEUMONIA; CONSULTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD; MORTALITY; PHYSICIAN; PRESCRIPTION;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLARITHROMYCIN; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DRUG UTILIZATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; ODDS RATIO; PNEUMONIA; PRESCRIPTIONS, DRUG; PREVENTIVE HEALTH SERVICES; RETROSPECTIVE STUDIES; SULFAMETHOXAZOLE; SURVIVAL RATE; TRIMETHOPRIM;

EID: 3142512599     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00553.x     Document Type: Article

References (33)

1. Feagan BC, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK (2000) Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Canadian Medical Association Journal, 162, 1411-1420.
2. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG (2000) A controlled trial of a critical pathway for treatment of community-acquired pneumonia. The Journal of the American Medical Association, 283, 741-755.
3. Fine M, Hough L, Medsger A et al. (1997) The hospital admission decision for patients with community-acquired pneumonia. Archives of Internal Medicine, 157, 31-44.
4. Bartlett JG, Mundy LM (1995) Community-acquired pneumonia. New England Journal of Medicine, 333, 1611-1624.
5. Metersky ML, Galusha DH, Meehan TP (1999) Improving the care of patients with community-acquired pneumonia. The Joint Commission on Accreditation of Healthcare Organization Journal, 25, 181-190.
6. Neiderman MS, McCombs J, Unger A, Kumar A, Popovian R (1998) The cost of treating community-acquired pneumonia. Clinical Therapeutics, 20, 821-836.
7. Fine JM, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN (1996) Prognosis and outcomes of patients with community-acquired pneumonia. The Journal of the American Medical Association, 275, 131-141.
8. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Archives of Internal Medicine, 159, 2561-2572.
9. Miletin MS, Chan CK (2001) The use of guidelines for the empirical treatment of hospital-acquired pneumonia. Canadian Respiratory Journal, 8, 251-260.
10. Fantin B, Aubert JP, Unger P, Lecoeur H, Carbon C (2001) Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France. Chest, 120, 181-192.
11. Gilbert K, Gleason PP, Singer DE et al. (1998) Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia. American Journal of Medicine, 104, 11-27.
12. Draper D, Kahn KL, Reinisch EJ et al. (1990) Studying the effects of the DRG based prospective payment system on quality of care. The Journal of the American Medical Association, 264, 1951-1961.
13. Marrie TJ, Durant H, Sealy E (1987) Pneumonia - the quality of medical records. Medical Care, 25, 21-24.
14. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, Canadian Infectious Disease Society, Canadian Thoracic Society (2000) Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Canadian Respiratory Journal, 7, 371-382.
15. Canadian Pharmacists Association (2002) Compendium of pharmaceuticals and specialties, 37th edn. Canadian Pharmacists Association, http://www.lb.ca.
16. Statistics Canada (1986). Canadian classification of diagnostic, therapeutic, and surgical procedures. Second Printing Statistics Canada Health Division, Nosology Reference Centre, Minister of Supply and Services. Ottawa: Statistics Canada.
17. Deyo RA, Gherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45, 611-619.
18. Romano PS, Roos LL, Jollis JG (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. Journal of Clinical Epidemiology, 46, 1071-1079.
19. Seber (1977) Linear regression analysis. New York, NY: Wiley.
20. Hosmer DW, Lemeshow S (1989) Applied logistic regression. New York, NY: John Wiley & Sons.
21. Cree M, Roos N, Yang Q, Carriere KC (2001) Hypertensive patients and their general practitioners. Healthcare Management Forum, 14, 31-40.
22. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clinical Infectious Diseases, 31, 341-382.
23. Gleason PP, Kapoor WN, Stone RA et al. (1997) Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. The Journal of the American Medical Association, 278, 31-39.
24. Marras TK, Chan CK (1998) Use of guidelines in treating community-acquired pneumonia. Chest, 113, 1681-1694.
25. Rothrock SG, Harper MB, Green SM et al. (1997) Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics, 99, 431-444.
26. Malcolm C, Marrie TJ (2003) Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Archives of Internal Medicine, 163, 791-802.
27. Gotfried MH (2001) Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1991-2000 respiratory surveillance program. American Journal of Medicine, 9A (Suppl. 111), 25S-29S.
28. Laurichesse H, Robin F, Gerbaud L, Pochet P, Gourdon F, Beytout J, Rey M, Study Group of General Practitioners (1998) Empirical therapy for non-hospitalized patients with community-acquired pneumonia. European Respiratory Journal, 11, 71-78.
29. Thornsberry C, Ogilvie P, Kahn J, Mauriz Y, The Laboratory Investigator Group (1997) Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1991-1997 respiratory season. Diagnostic Microbiology & Infectious Disease, 29, 241-257.
30. Garcia-Ordonez MA, Garcia-Jimenez JM, Paez F et al. (2001) Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. European Journal of Clinical Microbiology & Infectious Diseases, 20, 11-19.
31. Dubois RW, Brook RH (1988) Preventable deaths: who, how often, and why? Annals of Internal Medicine, 109, 581-589.
32. Ewig S, Ruiz M, Mensa J et al. (1998) Severe community-acquired pneumonia. Assessment of severity criteria. American Journal of Respiratory and Critical Care Medicine, 158, 1101-1108.
33. Koivula I, Sten M, Makela PH (1999) Prognosis after community-acquired pneumonia in the elderly: a population-based 11 year follow-up study. Archives of Internal Medicine, 159, 1551-1555.